NEW YORK, NY / ACCESS Newswire / September 24, 2025 / If you suffered a loss on your Charter Communications, Inc. (NASDAQ:CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/charter-communications-inc-lawsuit-submission-form?prid=169220&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / September 24, 2025 / If you suffered a loss on your LifeMD, Inc. (NASDAQ:LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=169221&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

PITTSBURGH, Sept. 24, 2025 (GLOBE NEWSWIRE) — Veradigm LLC (“Veradigm”), a health information technology company,1 recently announced a cybersecurity incident, which impacted the personal information of tens of thousands of individuals. In the incident, a cybercriminal hacker may have accessed records with personally identifiable information (“PII”) including name, contact details, date of birth, health records

Lynch Carpenter Investigates Claims in Veradigm LLC Data Breach GlobeNewswire September 24, 2025 PITTSBURGH, Sept. 24, 2025 (GLOBE NEWSWIRE) — Veradigm LLC (“Veradigm”), a health information technology company,1 recently announced a cybersecurity incident, which impacted the personal information of tens of thousands of individuals. In the incident, a cybercriminal hacker may have accessed records with

AcquisitionexpandsCrisil's benchmarkingofferingsacrosstheWealth Managementvaluechain PriceMetrixwillbeintegratedwithCrisilCoalition Greenwich(CCG),aleadingprovider ofstrategic benchmarking, analytics, and insights to the financial services industry Crisil, an S&P Global Company, announced the acquisition of McKinsey PriceMetrix Co. (“PriceMetrix”), a leading provider of performance benchmarking and data-driven insights for the wealth management industry. https://mma.prnewswire.com/media/2594759/Crisil_Limited_New_Logo.jpg PriceMetrix,basedinToronto, servesleadingwealth managementfirmsintheU.S.andCanada. Itsproprietarydatabase covers $8 trillion in assets under management and

(NasdaqGM:STAA), PHILADELPHIA, Sept. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of STAAR Surgical Company (NASDAQ: STAA) (“STAAR” or the “Company”) shareholders to determine whether the proposal is fair to investors. Click here for additional information: https://kaskelalaw.com/case/staar-surgical/ On

(NYSE:CTO), NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) and certain officers. The class action, filed in the United States District Court for the Middle District of Florida, and docketed under 25-cv-01516, is

Pomerantz Law Firm Announces the Filing of a Class Action Against CTO Realty Growth, Inc. and Certain Officers – CTO GlobeNewswire September 24, 2025 NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) and

STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options GlobeNewswire September 24, 2025 PHILADELPHIA, Sept. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kaskela Law LLC announces that it is investigating the

Ann Arbor, MI – AgelessRx, a leading telehealth longevity platform, today announced the rollout of its SGLT2 inhibitor therapy program, introducing Invokana(R) (canagliflozin) and Brenzavvy(R) (bexagliflozin) as clinically vetted tools for metabolic reset, anti-aging pathways, and overall healthspan extension. These offerings bring cutting-edge science into the standard of care for individuals seeking proven longevity benefits